Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Encompass Health (EHC)

Encompass Health Q4 diluted EPS rose 20.3% to $1.42; issues 2026 guidance

Positive Impact 3 of 5 earnings Written later

Encompass Health reported fourth-quarter 2025 net operating revenue of $1.54 billion, up 9.9% from a year earlier, and diluted earnings per share from continuing operations of $1.42, up from $1.18. The company also issued 2026 guidance, including adjusted earnings per share of $5.81 to $6.10, which gives shareholders a company-set benchmark for the year ahead.

Key points

  • Q4 2025 net operating revenue was $1.54 billion, up 9.9% from $1.41 billion in Q4 2024.
  • Q4 2025 adjusted EBITDA was $335.6 million, up 15.9%; adjusted EPS was $1.46, up 24.8%.
  • 2026 guidance: net operating revenue of $6.365 billion to $6.465 billion and adjusted EBITDA of $1.340 billion to $1.380 billion.
  • The company will hold its earnings call at 10:00 a.m. Eastern Time on February 6, 2026.

The filing

CompanyEncompass Health (EHC)
Form8-K, current report
Filed with the SECFeb 5, 2026, 4:23 PM ET
Accession number0000785161-26-000028

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.